http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107216276-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90ac57bee8cd3c71a9965dcf9721d266
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-27
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-27
filingDate 2017-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b4826ac15566e852af671c82514e2fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d89513821d0970c03e8669c1f188497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1827662e15f4470b49dd2f8d33552be9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d345b443fc97c4bf3c67ad509226f80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5285fcc2c4929ab4e79b865fc762e808
publicationDate 2017-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107216276-A
titleOfInvention A kind of synthetic method of new buvaracetam
abstract The invention provides a method for synthesizing buvaracetam. The method of the present invention takes cheap and easy-to-get valeric acid or valeryl halide as initial raw material, provides a brand-new new synthetic route for preparing brivaracetam (brivaracetam) medicine, and the total yield of the whole reaction route is high, and the advantage of the present invention is The production capacity is high, the cost is low, and it is suitable for large-scale industrial production.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020052545-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020051796-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019087172-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109655557-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114213306-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113336726-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114213305-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114213305-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112739683-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109593055-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109593055-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111170920-A
priorityDate 2017-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106588741-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106008411-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425960097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153273637

Total number of triples: 31.